Lyos Therapeutics
Company
A spin-off from MAPS, this pharmaceutical company has been conducting phase three clinical trials for MDMA-assisted therapy for PTSD.
Mentioned in 1 video
A spin-off from MAPS, this pharmaceutical company has been conducting phase three clinical trials for MDMA-assisted therapy for PTSD.